Medications for Neurodegenerative Diseases

5 results

  • Esomeprazole magnesium (esomeprazole magnesium)

    (Esomeprazole Magnesium)
    Torrent Pharmaceuticals Limited
    Usage: Esomeprazole magnesium for delayed-release oral suspension is indicated for the short-term treatment of erosive esophagitis and GERD symptoms in adults and pediatric patients. It also aids in the maintenance of healing, reduces NSAID-associated gastric ulcer risk, helps eradicate H. pylori, and treats pathological hypersecretory conditions.

  • Famotidine (famotidine)

    (Famotidine)
    Proficient Rx LP
    Usage: Famotidine Tablets are indicated for treating active duodenal and gastric ulcers, symptomatic nonerosive GERD, erosive esophagitis due to GERD, and pathological hypersecretory conditions in adults. They also reduce the risk of duodenal ulcer recurrence in adults and pediatric patients weighing 40 kg or greater.

  • Omeprazole (omeprazole)

    (Omeprazole)
    St. Mary's Medical Park Pharmacy
    Usage: Omeprazole delayed-release capsules are indicated for the short-term treatment of active duodenal and gastric ulcers, symptomatic GERD, erosive esophagitis due to GERD, and for maintaining healing of erosive esophagitis. It's also used for eradication of Helicobacter pylori to reduce ulcer recurrence and for long-term management of hypersecretory conditions.

  • Ranitidine (ranitidine)

    (Ranitidine)
    Amneal Pharmaceuticals of New York LLC
    Usage: Ranitidine Tablets are indicated for the short-term treatment of active duodenal and gastric ulcers, maintenance therapy after ulcer healing, treatment of GERD, and erosive esophagitis. They are also used in managing pathological hypersecretory conditions like Zollinger-Ellison syndrome, with symptomatic relief often occurring within 24 hours.

  • Ranitidine (ranitidine)

    (ranitidine)
    Par Pharmaceutical Inc
    Usage: Ranitidine is indicated for short-term treatment and maintenance of active duodenal and gastric ulcers, treatment of pathological hypersecretory conditions, GERD, and erosive esophagitis. Symptomatic relief typically occurs within 24 hours for GERD and erosive esophagitis after starting therapy.